References
- Obici L, Merlini G. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med Wkly 2012;142:w13580.
- Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000;7:64–69.
- Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356:2361–2371.
- Pinney JH, Hawkins PN. Amyloidosis. Ann Clin Biochem 2012; 49:229–241.
- Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24–29.
- Uguccioni M, Meliconi R, Lalli E, et al. Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia. J Clin Pathol 1992;45:348–351.
- Ueda M, Ando Y, Nakamura M, et al. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis. J Rheumatol 2006;33:2260–2270.